a
a
Weather:
No weather information available
HomeScienceImmortal Dragons Backs Etheros Pharmaceuticals: Targeting Aging-Related Disease with Breakthrough Catalytic Antioxidants

Immortal Dragons Backs Etheros Pharmaceuticals: Targeting Aging-Related Disease with Breakthrough Catalytic Antioxidants

SINGAPORE, Dec. 9, 2025 /PRNewswire/ — Immortal Dragons, the $40 million longevity-focused innovation fund, today announced its strategic investment in Etheros, a research-driven technology company developing proprietary water-soluble fullerene-based catalytic antioxidant materials….

No comments

Sorry, the comment form is closed at this time.

HomeScienceImmortal Dragons Backs Etheros Pharmaceuticals: Targeting Aging-Related Disease with Breakthrough Catalytic Antioxidants

Immortal Dragons Backs Etheros Pharmaceuticals: Targeting Aging-Related Disease with Breakthrough Catalytic Antioxidants

SINGAPORE, Dec. 9, 2025 /PRNewswire/ — Immortal Dragons, the $40 million longevity-focused innovation fund, today announced its strategic investment in Etheros, a research-driven technology company developing proprietary water-soluble fullerene-based catalytic antioxidant materials….

No comments

Sorry, the comment form is closed at this time.

Translate »